NAMS
Price
$23.55
Change
+$0.13 (+0.56%)
Updated
Jan 17 closing price
Capitalization
2.52B
69 days until earnings call
WXXWY
Price
$4.63
Change
+$0.14 (+3.11%)
Updated
Jan 17 closing price
Capitalization
9.45B
66 days until earnings call
Ad is loading...

NAMS vs WXXWY

Header iconNAMS vs WXXWY Comparison
Open Charts NAMS vs WXXWYBanner chart's image
NewAmsterdam Pharma
Price$23.55
Change+$0.13 (+0.56%)
Volume$553.02K
Capitalization2.52B
Wuxi Biologics (Cayman)
Price$4.63
Change+$0.14 (+3.11%)
Volume$14.63K
Capitalization9.45B
NAMS vs WXXWY Comparison Chart
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. WXXWY commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and WXXWY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (NAMS: $23.55 vs. WXXWY: $4.64)
Brand notoriety: NAMS and WXXWY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 55% vs. WXXWY: 30%
Market capitalization -- NAMS: $2.52B vs. WXXWY: $9.45B
NAMS [@Biotechnology] is valued at $2.52B. WXXWY’s [@Biotechnology] market capitalization is $9.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileWXXWY’s FA Score has 1 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • WXXWY’s FA Score: 1 green, 4 red.
According to our system of comparison, WXXWY is a better buy in the long-term than NAMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 1 TA indicator(s) are bullish while WXXWY’s TA Score has 3 bullish TA indicator(s).

  • NAMS’s TA Score: 1 bullish, 4 bearish.
  • WXXWY’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, WXXWY is a better buy in the short-term than NAMS.

Price Growth

NAMS (@Biotechnology) experienced а -5.61% price change this week, while WXXWY (@Biotechnology) price change was +8.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

NAMS is expected to report earnings on May 07, 2025.

WXXWY is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXXWY($9.45B) has a higher market cap than NAMS($2.52B). WXXWY YTD gains are higher at: 4.687 vs. NAMS (-8.366).
NAMSWXXWYNAMS / WXXWY
Capitalization2.52B9.45B27%
EBITDA-180.78MN/A-
Gain YTD-8.3664.687-179%
P/E RatioN/A28.32-
Revenue33.6MN/A-
Total Cash423MN/A-
Total Debt506KN/A-
FUNDAMENTALS RATINGS
WXXWY: Fundamental Ratings
WXXWY
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSWXXWY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
35%
Bullish Trend 11 days ago
83%
Momentum
ODDS (%)
Bearish Trend 11 days ago
38%
Bearish Trend 11 days ago
75%
MACD
ODDS (%)
Bearish Trend 11 days ago
40%
Bearish Trend 11 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
52%
Bearish Trend 11 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
54%
Bearish Trend 11 days ago
78%
Advances
ODDS (%)
Bullish Trend 17 days ago
73%
Bullish Trend 26 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
67%
Bearish Trend 12 days ago
75%
BollingerBands
ODDS (%)
N/A
Bullish Trend 11 days ago
80%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSFNX27.280.25
+0.92%
Hennessy Small Cap Financial Investor
RNWAX74.390.34
+0.46%
American Funds New World R1
PRUQX15.730.01
+0.06%
PGIM Jennison Utility R6
RSGRX30.96N/A
N/A
Victory RS Growth A
MRRGX36.85N/A
N/A
Meridian Growth Institutional

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with CMRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+0.56%
CMRX - NAMS
48%
Loosely correlated
-3.01%
QURE - NAMS
45%
Loosely correlated
-1.13%
GYRE - NAMS
32%
Poorly correlated
+1.39%
CRDF - NAMS
29%
Poorly correlated
+1.47%
IMCR - NAMS
26%
Poorly correlated
-0.27%
More

WXXWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXXWY has been loosely correlated with WXIBF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXXWY jumps, then WXIBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXXWY
1D Price
Change %
WXXWY100%
+3.00%
WXIBF - WXXWY
46%
Loosely correlated
N/A
ONC - WXXWY
36%
Loosely correlated
+2.31%
SNBIF - WXXWY
28%
Poorly correlated
N/A
NAMS - WXXWY
23%
Poorly correlated
+0.56%
ZLAB - WXXWY
23%
Poorly correlated
+2.64%
More